Wen-Zhao Zhong

Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma

Jian Su, Qing Zhou, Hai-Yan Tu, 2016, Clinical Cancer Research.

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression

Jian Su, Jun Zhao, Qing Zhou, 2018, BMC Cancer.

Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.

Qian Chu, Fan Yang, Zheng-Bo Han, 2019, Lung cancer.

The resistance mechanisms and treatment strategies for EGFR-mutant advanced non-small-cell lung cancer

Qing Zhou, Yi-long Wu, W. Zhong, 2017, Oncotarget.